FI924082A0 - Idiotypvaccination mot b-cellymfoma. - Google Patents

Idiotypvaccination mot b-cellymfoma.

Info

Publication number
FI924082A0
FI924082A0 FI924082A FI924082A FI924082A0 FI 924082 A0 FI924082 A0 FI 924082A0 FI 924082 A FI924082 A FI 924082A FI 924082 A FI924082 A FI 924082A FI 924082 A0 FI924082 A0 FI 924082A0
Authority
FI
Finland
Prior art keywords
dendritic cells
idiotype
pulsed
cells
idiotypvaccination
Prior art date
Application number
FI924082A
Other languages
English (en)
Other versions
FI105452B (fi
FI924082A (fi
Inventor
Heribert Bohlen
Jacques Urbain
Camp Benjamin Van
Kristiaan Thielemans
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23960532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI924082(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of FI924082A0 publication Critical patent/FI924082A0/fi
Publication of FI924082A publication Critical patent/FI924082A/fi
Application granted granted Critical
Publication of FI105452B publication Critical patent/FI105452B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI924082A 1990-03-14 1992-09-11 Idiotyyppirokotuksen valmistus B-solulymfoomaa vastaan FI105452B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49351190 1990-03-14
US07/493,511 US20030072751A1 (en) 1990-03-14 1990-03-14 Idiotypic vaccination against b cell lymphoma
PCT/US1991/001683 WO1991013632A1 (en) 1990-03-14 1991-03-13 Idiotypic vaccination against b cell lymphoma
US9101683 1991-03-13

Publications (3)

Publication Number Publication Date
FI924082A0 true FI924082A0 (fi) 1992-09-11
FI924082A FI924082A (fi) 1992-09-11
FI105452B FI105452B (fi) 2000-08-31

Family

ID=23960532

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924082A FI105452B (fi) 1990-03-14 1992-09-11 Idiotyyppirokotuksen valmistus B-solulymfoomaa vastaan

Country Status (12)

Country Link
US (1) US20030072751A1 (fi)
EP (1) EP0521897B1 (fi)
JP (1) JP2735947B2 (fi)
AT (1) ATE124265T1 (fi)
AU (1) AU645552B2 (fi)
CA (1) CA2078235C (fi)
DE (1) DE69110877T2 (fi)
DK (1) DK0521897T3 (fi)
ES (1) ES2074268T3 (fi)
FI (1) FI105452B (fi)
NO (1) NO308509B1 (fi)
WO (1) WO1991013632A1 (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004807A (en) * 1992-03-30 1999-12-21 Schering Corporation In vitro generation of human dendritic cells
DE69333433T2 (de) * 1992-04-01 2004-12-02 The Rockefeller University Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
AU687733B2 (en) * 1992-04-01 1998-03-05 Rockefeller University, The Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
WO1994002167A1 (en) * 1992-07-22 1994-02-03 The Trustees Of Princeton University p53 VACCINE
WO1994004659A1 (en) * 1992-08-21 1994-03-03 United States Of America, As Represented By The Secretary, Department Of Health & Human Services A novel b-lymphoma cell line and antigen
US5651993A (en) 1992-11-18 1997-07-29 Yale University Specific immune system modulation
WO1994021287A1 (en) * 1993-03-15 1994-09-29 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Peptide coated dendritic cells as immunogens
CA2192655A1 (en) * 1994-06-14 1995-12-21 Edgar G. Engleman Methods for in vivo t cell activation by antigen-pulsed dendritic cells
US6300090B1 (en) 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
US6010905A (en) * 1995-01-27 2000-01-04 The United States Of America As Represented By The Department Of Health & Human Services Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells
US6340981B1 (en) 1997-06-30 2002-01-22 Sun Microsystems, Inc. Method and apparatus for stroke substitution
US5788963A (en) * 1995-07-31 1998-08-04 Pacific Northwest Cancer Foundation Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
AU1152397A (en) * 1995-12-20 1997-07-14 Board Of Trustees Of The Leland Stanford Junior University Methods for in vivo t cell activation by antigen-pulsed dendritic cells
US6080409A (en) * 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
US7659119B2 (en) 1996-02-12 2010-02-09 Argos Therapeutics, Inc. Method and compositions for obtaining mature dendritic cells
US5776746A (en) 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods
US6274378B1 (en) 1997-10-27 2001-08-14 The Rockefeller University Methods and compositions for obtaining mature dendritic cells
WO1999042564A2 (en) 1998-02-20 1999-08-26 The Rockefeller University Apoptotic cell-mediated antigen presentation to dendritic cells
CA2368855C (en) 1999-04-20 2012-05-29 Richard Leslie Edelson Differentiation of monocytes into functional dendritic cells
US8313945B2 (en) 1999-04-20 2012-11-20 Yale University Methods for inducing the differentiation of blood monocytes into functional dendritic cells
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
AT409086B (de) * 1999-11-16 2002-05-27 Igeneon Krebs Immuntherapie Neue verwendung von antikörpern als impfstoffe
US8524495B2 (en) 2007-05-16 2013-09-03 Yale University Methods for inducing the differentiation of blood monocytes into functional dendritic cells

Also Published As

Publication number Publication date
NO923542L (no) 1992-09-11
CA2078235A1 (en) 1991-09-15
DE69110877D1 (de) 1995-08-03
AU645552B2 (en) 1994-01-20
FI105452B (fi) 2000-08-31
US20030072751A1 (en) 2003-04-17
EP0521897B1 (en) 1995-06-28
JPH05507905A (ja) 1993-11-11
NO308509B1 (no) 2000-09-25
ES2074268T3 (es) 1995-09-01
EP0521897A1 (en) 1993-01-13
FI924082A (fi) 1992-09-11
DK0521897T3 (da) 1995-11-13
AU7488691A (en) 1991-10-10
ATE124265T1 (de) 1995-07-15
DE69110877T2 (de) 1995-11-16
CA2078235C (en) 2004-01-20
WO1991013632A1 (en) 1991-09-19
NO923542D0 (no) 1992-09-11
JP2735947B2 (ja) 1998-04-02

Similar Documents

Publication Publication Date Title
FI924082A (fi) Idiotypvaccination mot b-cellymfoma
IT1248760B (it) Dispositivo di iniezione del combustibile per motori e endotermici
DE69033700T2 (de) Il-11 aus säugetier
IT1174641B (it) Metodo e dispositivo per iniezione di combustibile
DE3854174D1 (de) Kraftstoffeinspritzventil.
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
MY135673A (en) Monoclonal antibodies for inducing tolerance
IT1204630B (it) Iniettori di combustibile
IT1167325B (it) Polverizzatore per iniettori del combustibile di motori diesel
DE3886126D1 (de) Brennstoffeinspritzventil.
DE68917138T2 (de) Toleranzinduktion gegenüber einem fremdantigen.
IT1204628B (it) Inietori di combustibile
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
Thonard Host defense mechanisms in the oral mucosa
NO872633L (no) Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav.
IT1229943B (it) Procedimento e dispositivo di misura dell'anticipo di inizio mandata dell'iniezione, particolarmente in motori diesel
IT1215796B (it) Iniettore di carburante.
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
IT1181513B (it) Sistema di fissaggio dell'imbottitura sui fianchi di una poltrona
RO84177B1 (ro) Metoda de rahianestezie
ITMI913291A0 (it) Dispositivo e procedimento di iniezione del combustibile
SE8702038D0 (sv) Sett och anordning for att alstra seismiska pulser
ES556316A0 (es) Dispositivo verificador de inyectores de combustible
ES1005333Y (es) Dispositivo de sujeccion de tapizado de muebles en general.

Legal Events

Date Code Title Description
MA Patent expired